3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Mild Dementia: new trials by email Literature Review of Mild Dementia trials Research Report on Mild Dementia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD) SAGE-718, SAGE-718-matching Placebo - Mild Cognitive Impairment, Mild Dementia | Phase 2 | Completed | Supernus Pharmaceuticals, Inc. | 174 | 2022-11-29 | 2025-09-15 |
| A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate AD Biological/Vaccine: Bacillus Calmette-Guerin (BCG) - Mild Cognitive Impairment, Mild Dementia | Phase 2 | Completed | Steven E Arnold, MD | 15 | 2022-03-25 | 2025-04-13 |
| A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD) SAGE-718 - Alzheimer Disease, Cognitive Dysfunction | Phase 2 | Completed | Supernus Pharmaceuticals, Inc. | 26 | 2020-12-07 | 2025-09-15 |
Alzheimer Disease (3) · Cognitive Dysfunction (3)
Brain Diseases (3) · Central Nervous System Diseases (3) · Cognition Disorders (3) · Dementia (3) · Mental Disorders (3) · Nervous System Diseases (3) · Neurocognitive Disorders (3) · Neurodegenerative Diseases (3) · Tauopathies (3)
BCG Vaccine (1) · Biological Products (1)
Supernus Pharmaceuticals, Inc. (2) · Steven E Arnold, MD (1)
United States (3) · Puerto Rico (1)